{ "@context": "http:\/\/schema.org", "@type": "Article", "image": "https:\/\/sandiegouniontribune.esdiario.info\/wp-content\/s\/2024\/09\/SUT-L-NOVARTIS-MANUFACTURING-0910-01.jpg?w=150&strip=all", "headline": "Amid tariff turmoil, Swiss drugmaker commits to build $1.1B research hub in San Diego", "datePublished": "2025-04-10 19:54:00", "author": { "@type": "Person", "workLocation": { "@type": "Place" }, "Point": { "@type": "Point", "Type": "Journalist" }, "sameAs": [ "https:\/\/sandiegouniontribune.esdiario.info\/author\/natallie-rochasduniontribune-com\/" ], "name": "Natallie Rocha" } } Skip to content
An associate examines materials inside the refrigeration room of Novartis Pharmaceuticals' radioligand therapy (RLT) manufacturing facility in Indianapolis. The company is building a new manufacturing site in Carlsbad as part of its $23 billion investment in U.S. operations over the next five years. (Novartis Pharmaceuticals)
Novartis Pharmaceuticals
An associate examines materials inside the refrigeration room of Novartis Pharmaceuticals’ radioligand therapy (RLT) manufacturing facility in Indianapolis. The company is building a new manufacturing site in Carlsbad as part of its $23 billion investment in U.S. operations over the next five years. (Novartis Pharmaceuticals)
UPDATED:

Novartis plans to make San Diego the center of its West Coast research hub.

Subscribe to continue reading this article.

Already subscribed? To , click here.

Originally Published:

RevContent Feed

Events